OHK Medical Devices, Inc. develops and manufactures surgical tourniquets under the HemaClear brand (www.hemaclear.com). HemaClear helps prepare patients for any orthopedic procedure in just 12 seconds.

With more than 500,000 procedures performed to date, the tourniquet is becoming a standard of care in operating rooms in many countries. It is regularly used in leading hospitals such as The Hospital for Special Surgery in New York, Sinai Hospital of Baltimore, and the Shriners Hospitals for Children.

HemaClear exsanguinating tourniquets are unique:

• No blood leaks – The device exsanguinates more than 95% blood from the extremity.
• Offers a wider surgical field – Surgery is easier to perform as the narrow profile of the device offers maximal exposure of the surgery area.
• Sterile, single use – Sterility is ensured100% of the time. This eliminates the need for any reprocessing.
• Ready to go in seconds – Only seconds to apply. Training takes minutes.
• Cost effective – No need for bulky equipment, making use extremely economical.

For more information or to schedule your free evaluation, contact us at: info@hemaclear.com

Health Care

Manufacturing

Medical Devices

HemaClear by OHK medical devices

HemaClear by OHK medical devices' headquarters in Grandville, MI, United States

Sharon Abadi

Maya Hivner Azulay

Zamir Segev

Prof. Noam Gavriely

Larry Murdock

Oded Fishelzon

Erin Solaro

Eric Cooper

HemaClear by OHK medical devices

Org chart

Teams

Offices

Similar companies